{"id":9234,"date":"2020-06-29T15:22:41","date_gmt":"2020-06-29T19:22:41","guid":{"rendered":"https:\/\/imedcprod.wpengine.com\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\/"},"modified":"2020-06-29T15:22:41","modified_gmt":"2020-06-29T19:22:41","slug":"mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb","status":"publish","type":"news","link":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\/","title":{"rendered":"MNC r\u00e9agit \u00e0 la d\u00e9cision de la Cour f\u00e9d\u00e9rale relativement aux modifications \u00e0 la r\u00e9glementation du CEMPB"},"content":{"rendered":"<p><strong>Ottawa, le 29 juin <\/strong><strong>2020<\/strong> \u2013 M\u00e9dicaments novateurs Canada a publi\u00e9 aujourd\u2019hui la d\u00e9claration suivante en r\u00e9ponse \u00e0 la d\u00e9cision de la Cour f\u00e9d\u00e9rale du Canada concernant sa demande de contr\u00f4le judiciaire relativement aux modifications apport\u00e9es par le Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s au <em>R\u00e8glement sur les m\u00e9dicaments brevet\u00e9s<\/em> du Canada\u00a0:<\/p>\n<p>\u00ab\u00a0Nous venons de recevoir la d\u00e9cision de la Cour f\u00e9d\u00e9rale et nous l\u2019examinons avec nos membres et nos avocats-conseils pour \u00e9valuer son impact.<\/p>\n<p>\u00ab\u00a0Nous restons pr\u00e9occup\u00e9s par l\u2019impact n\u00e9gatif que le <em>R\u00e8glement sur les m\u00e9dicaments brevet\u00e9s<\/em> modifi\u00e9 aura sur l\u2019acc\u00e8s des Canadiens \u00e0 des m\u00e9dicaments novateurs et abordables, et sur la capacit\u00e9 du pays \u00e0 attirer des investissements dans notre secteur des sciences de la vie.<\/p>\n<p>\u00ab\u00a0L\u2019industrie des m\u00e9dicaments novateurs a d\u00e9montr\u00e9 son r\u00f4le vital dans la sant\u00e9 et le bien-\u00eatre des Canadiens pendant la crise de la COVID-19, et nous devons favoriser un environnement r\u00e9glementaire qui l\u2019encourage \u00e0 cro\u00eetre et \u00e0 prosp\u00e9rer.<\/p>\n<p>\u00ab\u00a0Nous examinerons attentivement la d\u00e9cision avec nos membres afin d\u2019\u00e9valuer son impact sur les patients et sur l\u2019investissement, et de d\u00e9terminer les prochaines \u00e9tapes.\u00a0\u00bb<\/p>\n<h2>\u00c0 propos de M\u00e9dicaments novateurs Canada<\/h2>\n<p>D\u00e9couvrez comment nos compagnies membres <a href=\"https:\/\/innovativemedicines.ca\/fr\/covid-19\/\" target=\"_blank\" rel=\"noopener noreferrer\">contribuent \u00e0 la lutte contre la COVID-19<\/a>.<\/p>\n<p>M\u00e9dicaments novateurs Canada est la voix nationale de l\u2019industrie pharmaceutique innovatrice canadienne. Nous plaidons en faveur de politiques qui permettent la d\u00e9couverte, le d\u00e9veloppement et la commercialisation de m\u00e9dicaments et vaccins novateurs qui am\u00e9liorent la vie de tous les Canadiens. Nous appuyons l\u2019engagement de nos membres d\u2019\u00eatre un partenaire pr\u00e9cieux du syst\u00e8me de sant\u00e9 canadien.<\/p>\n<p style=\"text-align: center;\">\u2013 30 \u2013<\/p>\n<h2>Pour de plus amples renseignements\u00a0:<\/h2>\n<p>Sarah Dion-Marquis<br \/>\nDirectrice, M\u00e9dia et relations publiques<br \/>\nT\u00e9l\u00e9phone\u00a0: (613)\u00a0769-6510<br \/>\nCourriel\u00a0:\u00a0<a href=\"mailto:sdmarquis@imc-mnc.ca\">sdmarquis@imc-mnc.ca<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nous venons de recevoir la d\u00e9cision de la Cour f\u00e9d\u00e9rale [&#8230;]<\/p>\n","protected":false},"featured_media":0,"template":"","topic":[],"team-member-id":[],"news-category":[176],"news-tag":[],"class_list":["post-9234","news","type-news","status-publish","hentry","news-category-communique"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MNC r\u00e9agit \u00e0 la d\u00e9cision de la Cour f\u00e9d\u00e9rale relativement aux modifications \u00e0 la r\u00e9glementation du CEMPB - Innovative Medicines Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MNC r\u00e9agit \u00e0 la d\u00e9cision de la Cour f\u00e9d\u00e9rale relativement aux modifications \u00e0 la r\u00e9glementation du CEMPB - Innovative Medicines Canada\" \/>\n<meta property=\"og:description\" content=\"Nous venons de recevoir la d\u00e9cision de la Cour f\u00e9d\u00e9rale [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovative Medicines Canada\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\\\/\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\\\/\",\"name\":\"MNC r\u00e9agit \u00e0 la d\u00e9cision de la Cour f\u00e9d\u00e9rale relativement aux modifications \u00e0 la r\u00e9glementation du CEMPB - Innovative Medicines Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/#website\"},\"datePublished\":\"2020-06-29T19:22:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Newsroom\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/newsroom\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Newsroom\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/newsroom\\\/all-news\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"MNC r\u00e9agit \u00e0 la d\u00e9cision de la Cour f\u00e9d\u00e9rale relativement aux modifications \u00e0 la r\u00e9glementation du CEMPB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/\",\"name\":\"Innovative Medicines Canada\",\"description\":\"Transforming Canadians\u2019 lives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MNC r\u00e9agit \u00e0 la d\u00e9cision de la Cour f\u00e9d\u00e9rale relativement aux modifications \u00e0 la r\u00e9glementation du CEMPB - Innovative Medicines Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\/","og_locale":"fr_FR","og_type":"article","og_title":"MNC r\u00e9agit \u00e0 la d\u00e9cision de la Cour f\u00e9d\u00e9rale relativement aux modifications \u00e0 la r\u00e9glementation du CEMPB - Innovative Medicines Canada","og_description":"Nous venons de recevoir la d\u00e9cision de la Cour f\u00e9d\u00e9rale [...]","og_url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\/","og_site_name":"Innovative Medicines Canada","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\/","url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\/","name":"MNC r\u00e9agit \u00e0 la d\u00e9cision de la Cour f\u00e9d\u00e9rale relativement aux modifications \u00e0 la r\u00e9glementation du CEMPB - Innovative Medicines Canada","isPartOf":{"@id":"https:\/\/innovativemedicines.ca\/fr\/#website"},"datePublished":"2020-06-29T19:22:41+00:00","breadcrumb":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/mnc-reagit-a-la-decision-de-la-cour-federale-relativement-aux-modifications-a-la-reglementation-du-cempb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innovativemedicines.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Newsroom","item":"https:\/\/innovativemedicines.ca\/fr\/newsroom\/"},{"@type":"ListItem","position":3,"name":"Newsroom","item":"https:\/\/innovativemedicines.ca\/fr\/newsroom\/all-news\/"},{"@type":"ListItem","position":4,"name":"MNC r\u00e9agit \u00e0 la d\u00e9cision de la Cour f\u00e9d\u00e9rale relativement aux modifications \u00e0 la r\u00e9glementation du CEMPB"}]},{"@type":"WebSite","@id":"https:\/\/innovativemedicines.ca\/fr\/#website","url":"https:\/\/innovativemedicines.ca\/fr\/","name":"Innovative Medicines Canada","description":"Transforming Canadians\u2019 lives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news\/9234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media?parent=9234"}],"wp:term":[{"taxonomy":"topic","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/topic?post=9234"},{"taxonomy":"team-member-id","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/team-member-id?post=9234"},{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-category?post=9234"},{"taxonomy":"news-tag","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-tag?post=9234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}